Recent news and posts
Finnish Laboratory Tests Nomenclature updated in July 2022
On July 1, 2022, the Laboratory Tests Nomenclature (Laboratoriotutkimusnimikkeistö) was updated in Finland. The validity period of seven coronavirus tests was extended until June 30, 2023. Some examples of these tests are listed below:
- 7900 “Panbio COVID-19 Ag Rapid Test, Abbott Rapid Diagnostics”;
- 7901 “Flowflex SARS-CoV-2 Antigen rapid test, ACON Laboratories, Inc”;
- 7902 “mariPOC SARS-CoV-2, ArcDia International Ltd”;
- 7905 “SARS-CoV-2 Antigen Rapid Test, Roche (SD BIOSENSOR)”.
Two new codes in the field of physiology were added:
- 6603 “Esophageal precision manometry, impedance measurement”;
- 6604 “Sleep impedance pneumography, long-term recording”.
The Laboratory Tests Nomenclature is maintained by the Association of Local and Regional Authorities. Nomenclature codes cover studies in clinical chemistry, clinical physiology, clinical microbiology, clinical neurophysiology, genetics, and pathology. Nomenclature codes are used for the unification of coding of laboratory procedures in Finland. The Laboratory Tests Nomenclature is also used to code the tests in private settings with coverage from the national public payor (KELA).
The full details in Finnish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services “HTA Alerts” and “Reimbursement Alerts” every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.